Navid Radfar, Dhir Gala, Harsh Singh, Juan Bello, Joseph Allencherril. De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making. // American Journal of Cardiovascular Drugs. – 2026. – DOI: 10.1007/s40256-026-00806-8. – URL: https://doi.org/10.1007/s40256-026-00806-8
Navid Radfar, Dhir Gala, Harsh Singh, Juan Bello, & Joseph Allencherril (2026). De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-026-00806-8
Navid Radfar, et al. “De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making.” American Journal of Cardiovascular Drugs, 2026. doi:10.1007/s40256-026-00806-8.
@article{Radfar2026,
title = {De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making},
author = {Radfar, Navid and Gala, Dhir and Singh, Harsh and Bello, Juan and Allencherril, Joseph},
journal = {American Journal of Cardiovascular Drugs},
year = {2026},
doi = {10.1007/s40256-026-00806-8},
url = {https://doi.org/10.1007/s40256-026-00806-8}
}